Acute Leukemia of Ambiguous Lineage — Trials

Acute Leukemia of Ambiguous Lineage — Trials · CancerIndex

Clinical trials

Registered studies

139 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 65
Recruiting: 38
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (20)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03957915	Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia(INA03)	completed	Early Phase 1	33	Institut Paoli-CalmettesOTHER	1	Aug 6, 2025	clinicaltrials

Data updated 22 days agoSource updated Aug 6, 2025source: clinicaltrials